Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name NKTR-255
Trade Name
Synonyms NKTR255|NKTR 255
Drug Descriptions

NKTR-255 comprises polymer-conjugated human IL-15, which binds to the IL-15 receptor and acts as an agonist, potentially resulting in enhanced anti-tumor immune response in combination with antibody therapies (Cancer Res July 1 2019 (79) (13 Supplement) 3265).

CAS Registry Number NA
NCIT ID C165666


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Avelumab + NKTR-255 Avelumab NKTR-255 0 1
Cetuximab + NKTR-255 Cetuximab NKTR-255 0 1
Daratumumab + NKTR-255 Daratumumab NKTR-255 0 1
Durvalumab + NKTR-255 Durvalumab NKTR-255 0 1
NKTR-255 NKTR-255 0 4

Additional content available in CKB BOOST